Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | CSNK1G2 |
| Upstream (Parents) |
|---|
| (<<) CALR → CSNK1G2 |
| (<<) TCF25 → CSNK1G2 |
| (<<) LIN37 → CSNK1G2 |
| (<<) UPF1 → CSNK1G2 |
| Downstream (Children) |
|---|
| CSNK1G2 → HSP90B1 (>>) |
| CSNK1G2 → SETD2 (>>) |
| CSNK1G2 → FZR1 (>>) |
| CSNK1G2 → ENDOU (>>) |
| CSNK1G2 → INO80B (>>) |
| CSNK1G2 → PPP1R3D (>>) |
| CSNK1G2 → ADCYAP1 (>>) |
| CSNK1G2 → LIN37 (>>) |
| CSNK1G2 → GMEB1 (>>) |
| CSNK1G2 → HOXC5 (>>) |
| CSNK1G2 → KLHL24 (>>) |
| CSNK1G2 → SRC (>>) |
| CSNK1G2 → ADRA2C (>>) |
| CSNK1G2 → RORB (>>) |
| CSNK1G2 → RGS14 (>>) |
| CSNK1G2 → MYST3 (>>) |
| CSNK1G2 → RGS11 (>>) |
| CSNK1G2 → CDK11A///CDK11B (>>) |
| CSNK1G2 → HRK (>>) |
| CSNK1G2 → SFRS8 (>>) |
| CSNK1G2 → UPF1 (>>) |
| CSNK1G2 → C1orf95 (>>) |
